Sutro Biopharma, Inc. - Common Stock, $0.001 par value (STRO)

CUSIP: 869367102

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class
Equity / Common Stock, $0.001 par value
Shares outstanding
84,733,230
Total 13F shares
39,392,744
Share change
+8,003,533
Total reported value
$855,224,796
Put/Call ratio
60%
Price per share
$21.71
Number of holders
132
Value change
+$184,675,658
Number of buys
99
Number of sells
30

Quarterly Holders Quick Answers

What is CUSIP 869367102?
CUSIP 869367102 identifies STRO - Sutro Biopharma, Inc. - Common Stock, $0.001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Sutro Biopharma, Inc. - Common Stock, $0.001 par value (STRO) as of Q4 2020

As of 31 Dec 2020, Sutro Biopharma, Inc. - Common Stock, $0.001 par value (STRO) was held by 132 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 39,392,744 shares. The largest 10 holders included BlackRock Inc., EVENTIDE ASSET MANAGEMENT, LLC, FRANKLIN RESOURCES INC, RA CAPITAL MANAGEMENT, L.P., VANGUARD GROUP INC, BVF INC/IL, SV Health Investors, LLC, BAILLIE GIFFORD & CO, Samsara BioCapital, LLC, and Point72 Asset Management, L.P.. This page lists 132 institutional shareholders reporting positions in this security for the Q4 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.